ALZHEON, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • August 27th, 2018 • Alzheon, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of ______________, 20[18] between Alzheon, Inc., a Delaware corporation (the “Company”), and [Name] (“Indemnitee”).
LEASE AGREEMENT between and ALZHEON, INC., as Tenant Framingham, Massachusetts December 29, 2014Lease Agreement • August 27th, 2018 • Alzheon, Inc. • Pharmaceutical preparations • Massachusetts
This Lease Agreement (“Lease”) is made and entered into as of December 29, 2014, by and between 111 MPA LLC, a Delaware limited liability company with its principal place of business at c/o Marcus Partners, Inc., 260 Franklin Street, Suite 620, Boston, Massachusetts 02110 (the “Landlord”) and ALZHEON, INC., a Delaware corporation with its principal place of business at 11 Speen Street, Framingham, Massachusetts 01701 (the “Tenant”).
ContractLicense Agreement • August 27th, 2018 • Alzheon, Inc. • Pharmaceutical preparations • New York
[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
ALZHEON, INC. AMENDED AND RESTATED STOCKHOLDERS AGREEMENTStockholders Agreement • August 27th, 2018 • Alzheon, Inc. • Pharmaceutical preparations • Delaware
This AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “Agreement”), is made as of May 25, 2017, by and among Alzheon, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto (together with any subsequent investors or transferees, who become parties hereto as “Investors” pursuant to Subsections 9.9(a) or 9.12 below, the “Investors”), and those certain stockholders of the Company listed on Schedule B (together with any subsequent stockholders or transferees, who become parties hereto as “Key Holders” pursuant to Subsection 9.9(b) or 9.12 below, the “Key Holders,” and together collectively with the Investors, the “Stockholders”).
